Imanin Overview

  • Status
  • Private

  • Employees
  • 1

Employees
  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $25K

  • Investors
  • 1

Imanin General Information

Description

Developer of ultrasound-based preventative diagnostic tools intended for cardiovascular diseases. The company develops a prototype, for carotid intima-media thickness (CIMT) image interpretation, enabling healthcare professionals to have tools that are more efficient and available for widespread clinical adoption.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Monitoring Equipment
Primary Office
  • Tempe, AZ
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Imanin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 19-Nov-2012 $25K 0000 Completed Startup
To view Imanin’s complete valuation and funding history, request access »

Imanin Patents

Imanin Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20050141185-A1 Display enhancement device for wireless communication products Inactive 24-Jun-2003 000000000 00

Imanin Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Imanin Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ASU Venture Catalyst Accelerator/Incubator Minority 000 0000 000000 0
To view Imanin’s complete investors history, request access »